Colgate-Palmolive (NYSE:CL) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP trimmed its position in Colgate-Palmolive (NYSE:CL) by 52.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 606,621 shares of the company’s stock after selling 672,617 shares during the period. Bridgewater Associates LP’s holdings in Colgate-Palmolive were worth $62,973,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently made changes to their positions in the company. B. Riley Wealth Advisors Inc. grew its position in Colgate-Palmolive by 0.8% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock worth $1,498,000 after purchasing an additional 138 shares during the period. Tidal Investments LLC grew its position in Colgate-Palmolive by 31.1% during the 1st quarter. Tidal Investments LLC now owns 61,646 shares of the company’s stock worth $5,551,000 after purchasing an additional 14,631 shares during the period. Hancock Whitney Corp grew its position in Colgate-Palmolive by 1.3% during the 1st quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock worth $1,082,000 after purchasing an additional 151 shares during the period. Beacon Capital Management LLC grew its position in Colgate-Palmolive by 460.0% during the 1st quarter. Beacon Capital Management LLC now owns 840 shares of the company’s stock worth $76,000 after purchasing an additional 690 shares during the period. Finally, iA Global Asset Management Inc. grew its position in Colgate-Palmolive by 41.2% during the 1st quarter. iA Global Asset Management Inc. now owns 44,447 shares of the company’s stock worth $4,002,000 after purchasing an additional 12,965 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have weighed in on CL. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Trading Up 1.3 %

CL opened at $96.59 on Wednesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company’s 50 day simple moving average is $97.74 and its two-hundred day simple moving average is $98.59. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The firm has a market capitalization of $78.91 billion, a price-to-earnings ratio of 27.68, a price-to-earnings-growth ratio of 3.40 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.